Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · IEX Real-Time Price · USD
6.38
+0.53 (9.06%)
At close:
Jun 2, 2023, 4:00 PM
6.25
-0.13 (-2.04%)
After-hours:
Jun 2, 2023, 5:22 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40 | 26.54 | 11.24 | 0 | 0 | 0.43 | 29.98 | 0.99 | 2.24 | 1.33 | |
| Revenue Growth (YoY) | 50.69% | 136.24% | - | - | - | -98.58% | 2928.38% | -55.86% | 68.14% | - | |
| Gross Profit | 40 | 26.54 | 11.24 | 0 | 0 | 0.43 | 29.98 | 0.99 | 2.24 | 1.33 | |
| Selling, General & Admin | 39.79 | 29.39 | 14.3 | 12.21 | 11.62 | 8.07 | 14.74 | 9.85 | 8.47 | 4.02 | |
| Research & Development | 38.59 | 25.31 | 29.19 | 24.66 | 14.08 | 12.51 | 13.48 | 26.34 | 26.7 | 13.79 | |
| Other Operating Expenses | 39.53 | 37.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Operating Expenses | 117.91 | 91.93 | 43.49 | 36.87 | 25.7 | 20.58 | 28.22 | 36.19 | 35.17 | 17.81 | |
| Operating Income | -77.91 | -65.39 | -32.26 | -36.87 | -25.7 | -20.16 | 1.77 | -35.2 | -32.93 | -16.48 | |
| Interest Expense / Income | 0 | 0 | 0 | 0 | 0 | 0 | 0.25 | 1.4 | 0.38 | 1.4 | |
| Other Expense / Income | -54.15 | -56.78 | -11.31 | 70.63 | 7.99 | 8.87 | -0.38 | -3.14 | 0.85 | 0.15 | |
| Pretax Income | -23.76 | -8.61 | -20.95 | -107.5 | -33.69 | -29.03 | 1.9 | -33.45 | -34.16 | -18.03 | |
| Income Tax | -3.88 | -8.27 | 1.45 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | |
| Net Income | -19.88 | -0.34 | -22.4 | -107.5 | -33.69 | -29.03 | 1.89 | -33.45 | -34.16 | -18.03 | |
| Preferred Dividends | 0 | 0 | 0.15 | 0 | 0 | 0 | 0 | 0 | 0.52 | 3.86 | |
| Net Income Common | -19.88 | -0.34 | -22.54 | -107.5 | -33.69 | -29.03 | 1.89 | -33.45 | -34.68 | -21.88 | |
| Shares Outstanding (Basic) | 10 | 9 | 6 | 5 | 3 | 1 | 1 | 1 | 1 | 0 | |
| Shares Outstanding (Diluted) | 10 | 9 | 6 | 5 | 3 | 1 | 1 | 1 | 1 | 0 | |
| Shares Change | 9.99% | 54.22% | 30.01% | 47.20% | 136.64% | 20.12% | 14.43% | 29.70% | 983.14% | 36.15% | |
| EPS (Basic) | -2.00 | - | -3.80 | -23.60 | -11.00 | -22.20 | 1.80 | -35.20 | -47.40 | -323.60 | |
| EPS (Diluted) | -2.00 | - | -3.80 | -23.60 | -11.00 | -22.20 | 1.80 | -35.20 | -47.40 | -323.60 | |
| Free Cash Flow Per Share | 2.49 | -7.56 | -5.22 | -8.28 | -7.39 | -13.54 | 2.72 | -36.66 | -40.21 | -199.62 | |
| Gross Margin | 100.00% | 100.00% | 100.00% | - | - | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
| Operating Margin | -194.77% | -246.34% | -287.09% | - | - | -4742.35% | 5.89% | -3555.15% | -1468.17% | -1235.23% | |
| Profit Margin | -49.71% | -1.27% | -200.64% | - | - | -6830.35% | 6.31% | -3378.99% | -1545.92% | -1640.33% | |
| Free Cash Flow Margin | 62.31% | -259.50% | -274.52% | - | - | -4156.94% | 9.55% | -3516.77% | -1312.71% | -1011.54% | |
| Effective Tax Rate | - | - | - | - | - | - | 0.26% | - | - | - | |
| EBITDA | -23.75 | -8.52 | -20.83 | -107.28 | -33.49 | -28.74 | 2.32 | -31.69 | -33.37 | -16.19 | |
| EBITDA Margin | -59.37% | -32.11% | -185.39% | - | - | -6763.29% | 7.74% | -3201.11% | -1487.74% | -1213.42% | |
| Depreciation & Amortization | 0.01 | 0.09 | 0.12 | 0.22 | 0.21 | 0.29 | 0.18 | 0.37 | 0.41 | 0.44 | |
| EBIT | -23.76 | -8.61 | -20.95 | -107.5 | -33.69 | -29.03 | 2.14 | -32.06 | -33.78 | -16.63 | |
| EBIT Margin | -59.40% | -32.43% | -186.47% | - | - | -6830.35% | 7.15% | -3238.08% | -1506.02% | -1246.25% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).